JHS Svendgaard Laboratories Share Price

NSE
13.21
-0.23 (0.00%)
JHS • 13 Jun, 2025 | 03:27 PM
BUY

1Y Annualised Return

-36.30%

3Y Annualised Return

-15.80%

5Y Annualised Return

-2.18%

The current prices are delayed, login or Open Demat Account for live prices.

JHS Svendgaard Laboratories SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹54,46,475 (-16.21%)

Daily SIP of 25,000 would have become 54,46,475 in 1 year with a gain of -10,53,524 (-16.21%)

JHS Svendgaard Laboratories Stock Performance
Today’s Low - High
12.82
13.70
12.82
13.70
52 Week Low - High
11.00
32.69
11.00
32.69

Open

13.40

Prev. Close

13.44

Total Traded Value

13.85 L

View details of Market Depth
JHS Svendgaard Laboratories Fundamental

Market Cap (in crs)

113.08

Face Value

10

Turnover (in lacs)

13.85

Key Metrics
Qtr Change %
59.59% Fall from 52W High
4.6
Dividend yield 1yr %
0

JHS Svendgaard Laboratories Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

JHS Svendgaard Laboratories Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
25.17 Cr
22.66 Cr
19.68 Cr
24.48 Cr
21.66 Cr

JHS Svendgaard Laboratories Yearly Revenue

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
94.87 Cr
75.11 Cr
110.6 Cr
95.64 Cr
108.31 Cr
152.95 Cr

JHS Svendgaard Laboratories Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
-6.96 Cr
-1.84 Cr
-10.32 Cr
-0.63 Cr
-0.75 Cr

JHS Svendgaard Laboratories Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
-19.74 Cr
-4.06 Cr
-16.78 Cr
-4.29 Cr
1.34 Cr
-4.86 Cr
JHS Svendgaard Laboratories Result Highlights
  • JHS Svendgaard Laboratories Ltd reported a 0.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 30.6%.

  • Its expenses for the quarter were down by 6.7% QoQ and 26.1% YoY.

  • The net profit decreased 59.2% QoQ and decreased 92.6% YoY.

  • The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd declined at 0.1 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

JHS Svendgaard Laboratories shareholding Pattern

Promoter
34.6%
Foreign Institutions
1.6%
Public
63.8%
Promoter
34.6%
Foreign Institutions
1.6%
Public
63.8%
Promoter
34.6%
Foreign Institutions
1.7%
Public
63.8%
Promoter
37.7%
Foreign Institutions
0.2%
Domestic Institutions
6%
Public
56%
Promoter
37.7%
Foreign Institutions
2.3%
Domestic Institutions
6.2%
Public
53.8%
Promoter
37.7%
Domestic Institutions
9.2%
Public
53.1%

JHS Svendgaard Laboratories Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
13.21
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
5Day EMA
13.30
10Day EMA
13.30
12Day EMA
13.40
20Day EMA
13.60
26Day EMA
13.60
50Day EMA
14.00
100Day EMA
15.40
200Day EMA
17.70
5Day SMA
13.30
10Day SMA
13.20
20Day SMA
13.60
30Day SMA
14.00
50Day SMA
13.90
100Day SMA
14.80
150Day SMA
17.30
200Day SMA
20.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
108045 Rs
108045 Rs
Week Rs
123094 Rs
123094 Rs
Month Rs
124869 Rs
124869 Rs
Resistance & Support
13.24
Pivot
Resistance
First Resistance
13.67
Second Resistance
14.12
Third Resistance
14.55
Support
First Support
12.79
Second support
12.36
Third Support
11.91
Relative Strength Index
44.28
Money Flow Index
63.18
MACD
-0.26
MACD Signal
-0.23
Average True Range
0.70
Average Directional Index
17.12
Rate of Change (21)
-15.86
Rate of Change (125)
-44.21
Shareholding
Name
Holding Percent
AEGIS INVESTMENT FUND PCC
1.57

JHS Svendgaard Laboratories Latest News

30 MAY 2025 | Friday

JHS Svendgaard Laboratories Ltd - 532771 - Compliances-Reg.24(A)-Annual Secretarial Compliance

29 MAY 2025 | Thursday

JHS Svendgaard Laboratories Ltd - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication

27 MAY 2025 | Tuesday

JHS Svendgaard Laboratories Ltd - 532771 - Annual Financial Results For The Quarter And Year Ended 31St March, 2025

View More

JHS Svendgaard Laboratories Company background

Founded in: 2004
Managing director: Nikhil Nanda.
JHS Svendgaard Laboratories Limited manufactures the entire range of oral care product at its ISOcertified state oftheart manufacturing facilities at Kala Amb (Himachal Pradesh). The Company was incorporated on October 8, 2004 in Himachal Pradesh by the Registrar of Companies, Punjab, Himachal Pradesh Chandigarh situated at Jalandhar with the main object to manufacture and or trade of/in dental/oral care products, which includes toothbrushes, toothpaste, tooth powder, mouth rinse, whitening gel, effervescent tablets, tongue cleaners etc. The company was promoted by Nikhil Nanda.Initially, they manufactured only toothbrushes but realizing the vast potential of the oral care market, they ventured into manufacturing of other dental care products like toothpastes, Mouthwash, Denture tablets etc. Some of the prominent brands with whom the Company has been associated with during its journey includes Amway India Enterprises Pvt. Ltd., Dabur India Limited, Patanjali Ayurved Limited, Hindustan Unilever Limited, Me N Moms Pvt. Ltd., Vestige Marketing Pvt. Ltd., Colgate Palmolive India Ltd., Elder Health Care Limited, J. L. Morisons India Limited,Dr. Fresh Inc., Boots, Lavoris, Walgreens, Walmart and many more recognized brands.In the year 2005, the company acquired the business from the three proprietary concerns namely Sunehari Svendgaard Laboratories, Sunehari Oral Care and Jai Hanuman Exports with effect from April 1, 2005. These three proprietary concerns became the three units of the company, namely Unit I SSL, Unit II SOC and Unit III JHE.In the year 2006, Unit IIIJHE was awarded the status of Star Export House (one Star) by the Government of India effective from April 1, 2005 to March 31, 2009.During the year 200607, the company increased the production capacity of Oral Care Products by 1.50 crore Pcs to 7.00 crore Pcs. In October 21, 2006, the company shares were listed on the Bombay Stock Exchange Ltd and the National Stock Exchange of India Ltd. In April 2, 2007, the company commenced the first phase of commercial Production at Kalaamb in Himachal Pradesh. In April 10, 2007, they acquired 9400 equity shares of Rs 10 each of Nikiven Personal Care Products Pvt Ltd NIKIVEN constituting 51.08% of the paidup capital. With this acquisition, Nikiven became a subsidiary of the company.During the year 200708, the company set up a 100% subsidiary company in Ras Al Khaimah Free Trade Zone, UAE with the name of Jones H Smith, FZE. In April 2008, they set up a subsidiary company with the name JHS Svendgaard Dental Care Ltd. During the year 200809, the company increased the production capacity of Oral Care Products by 13.02 crore Pcs to 24.62 crore Pcs. In February 4, 2009, they received the Best Performing Enterprise Award Runnerup (Turnover from Rs 26 to 100 crore) at Plasticon Awards 2009 for the oral care business with a Complete Range of Oral Care Products from The Plastindia Foundation. In April 2009, the company launched their own brand Dr. Gold, to use their experience in the oral care industry and encash the market opportunities.The Scheme of Amalgamation of M/s JHS Svendgaard Hygiene Products Limited and M/s Waves Hygiene Products (a Partnership Firm) with M/s JHS Svendgaard Laboratories had been approved by the Delhi High Court on 30th August, 2011 and by the Shimla High Court on 28 May, 2012. Resultantly, all the assets and liabilities of JHS Svendgaard Laboratories Limited (Transferor Company) and M/s. Waves Hygiene Products (Transferor Firm) was transferred to Company effective from 31 March, 2010, i.e. the Appointed Date.During 201718, M/s JHS Svendgaard Retail Ventures Pvt. Ltd. became the Subsidiary of the company with effect from April 13, 2018. JHS Svendgaard Brands Limited (formerly known as JHS Svendgaard Dental Care Limited) ceased to be Subsidiary of the Company w.e.f 01st September, 2020. During 202021, the Composite Scheme of Arrangement for Demerger of Retail Investment Division (Demerged Undertaking) of JHS Svendgaard Laboratories Limited (Demerged Company) and vesting of the same with JHS Svendgaard Retail Ventures Private Limited (Resulting Company) on a going concern basis and immediately thereupon, amalgamation of JHS Svendgaard Brands Limited (Transferor Company) with JHS Svendgaard Laboratories Limited (Transferee Company) was approved on 09th October, 2020.

As of 13 Jun, 2025, JHS share price is ₹13.2. The stock opened at ₹13.4 and had closed at ₹13.4 the previous day. During today’s trading session, JHS share price moved between ₹12.82 and ₹13.70, with an average price for the day of ₹12.50. Over the last 52 weeks, the stock has recorded a low of ₹11.00 and a high of ₹32.69. In terms of performance, JHS share price has declined by 43.8% over the past six months and has declined by 36.3% over the last year.

Read More

JHS Svendgaard Laboratories FAQs

JHS Svendgaard Laboratories share price is ₹13.21 in NSE and ₹13.4 in BSE as on 13/6/2025.

JHS Svendgaard Laboratories share price in the past 1-year return was -37.39. The JHS Svendgaard Laboratories share hit a 1-year low of Rs. 11 and a 1-year high of Rs. 32.69.

The market cap of JHS Svendgaard Laboratories is Rs. 113.08 Cr. as of 13/6/2025.

The PE ratios of JHS Svendgaard Laboratories is 0 as of 13/6/2025.

The PB ratios of JHS Svendgaard Laboratories is 0.65 as of 13/6/2025

You can easily buy JHS Svendgaard Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that JHS Svendgaard Laboratories stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -